Seminari di Ematologia Oncologica - Società Italiana di Ematologia

58 Seminari di Ematologia Oncologica
27. Thomas DA, O’Brien S, Cortes J, Giles FJ, Faderl S,
Verstovsek S, et al. Outcome with the hyper-CVAD regimens
in lymphoblastic lymphoma. Blood. 2004; 104:
1624-30.
28. Sweetenham JW, Santini G, Qian W, Guelfi M, Schmitz
N, Simnett S, et al. High-dose therapy and autologous
stem-cell transplantation versus conventional-dose
consolidation/maintenance therapy as postremission
therapy for adult patients with lymphoblastic lymphoma:
results of a randomized trial of the European
Group for Blood and Marrow Transplantation and the
United Kingdom Lymphoma Group. J Clin Oncol. 2001;
19: 2927-36.
29. Bailey LC, Lange BJ, Rheingold SR, Bunin NJ. Bone
marrow relapse in paediatric acute lymphoblastic leukaemia.
Lancet Oncol. 2008; 9: 873-83.
30. Bruggemann M, Raff T, Flohr T, Gokbuget N, Nakao
M, Droese J, et al. Clinical significance of minimal residual
disease quantification in adult patients with standard-risk
acute lymphoblastic leukemia. Blood. 2006;
107: 1116-23.
31. Nathwani BN, Diamond LW, Winberg CD, Kim H,
Bearman RM, Glick JH, et al. Lymphoblastic lymphoma:
a clinicopathologic study of 95 patients.
Cancer. 1981; 48: 2347-57.
32. Murphy SB. Management of childhood non-Hodgkin’s
lymphoma. Cancer Treat Rep. 1977; 61: 1161-73.
33. Aur RJ, Hustu HO, Simone JV, Pratt CB, Pinkel D.
Therapy of localized and regional lymphosarcoma of
childhood. Cancer. 1971; 27: 1328-31.
34. Wollner N, Exelby PR, Lieberman PH. Non-Hodgkin’s
lymphoma in children: a progress report on the original
patients treated with the LSA2-L2 protocol.
Cancer. 1979; 44: 1990-9.
35. Mora J, Filippa DA, Qin J, Wollner N. Lymphoblastic
lymphoma of childhood and the LSA2-L2 protocol: the
30-year experience at Memorial-Sloan-Kettering
Cancer Center. Cancer. 2003; 98: 1283-91.
36. Hvizdala EV, Berard C, Callihan T, Falletta J, Sabio H,
Shuster JJ, et al. Lymphoblastic lymphoma in children
- a randomized trial comparing LSA2-L2 with the A-
COP+ therapeutic regimen: a Pediatric Oncology Group
Study. J Clin Oncol. 1988; 6: 26-33.
37 Coleman CN, Picozzi VJ, Jr., Cox RS, McWhirter K,
Weiss LM, Cohen JR, et al. Treatment of lymphoblastic
lymphoma in adults. J Clin Oncol. 1986; 4: 1628-
37.
38. Mazza P, Bertini M, Macchi S, Lauria F, Pileri S, Rivano
MT, et al. Lymphoblastic lymphoma in adolescents and
adults. Clinical, pathological and prognostic evaluation.
Eur J Cancer Clin Oncol. 1986; 22: 1503-10.
39. Levine AM, Forman SJ, Meyer PR, Koehler SC,
Liebman H, Paganini-Hill A, et al. Successful therapy
of convoluted T-lymphoblastic lymphoma in the adult.
Blood. 1983; 61: 92-8.
40. Bernasconi C, Brusamolino E, Lazzarino M, Morra E,
Pagnucco G, Orlandi E. Lymphoblastic lymphoma in
adult patients: clinicopathological features and
response to intensive multiagent chemotherapy analogous
to that used in acute lymphoblastic leukemia.
Ann Oncol. 1990; 1: 141-6.
41. Levine JE, Harris RE, Loberiza FR, Jr., Armitage JO,
Vose JM, Van Besien K, et al. A comparison of allogeneic
and autologous bone marrow transplantation
for lymphoblastic lymphoma. Blood. 2003; 101:
2476-82.
42. Peniket AJ, Ruiz de Elvira MC, Taghipour G,
Cordonnier C, Gluckman E, de Witte T, et al. An
EBMT registry matched study of allogeneic stem cell
transplants for lymphoma: allogeneic transplantation
is associated with a lower relapse rate but a higher
procedure-related mortality rate than autologous
transplantation. Bone Marrow Transplant. 2003; 31:
667-78.
43. Le Gouill S, Lepretre S, Briere J, Morel P, Bouabdallah
R, Raffoux E, et al. Adult lymphoblastic lymphoma: a
retrospective analysis of 92 patients under 61 years
included in the LNH87/93 trials. Leukemia. 2003; 17:
2220-4.
44. Kim SW, Tanimoto TE, Hirabayashi N, Goto S, Kami
M, Yoshioka S, et al. Myeloablative allogeneic
hematopoietic stem cell transplantation for non-
Hodgkin lymphoma: a nationwide survey in Japan.
Blood. 2006; 108: 382-9.
45. Song KW, Barnett MJ, Gascoyne RD, Chhanabhai M,
Forrest DL, Hogge DE, et al. Primary therapy for adults
with T-cell lymphoblastic lymphoma with hematopoietic
stem-cell transplantation results in favorable outcomes.
Ann Oncol. 2007; 18: 535-40.
46. Larson RA. Three new drugs for acute lymphoblastic
leukemia: nelarabine, clofarabine, and forodesine.
[Abstract]. Sem Oncol. 2007; 34 (Suppl 5): S13-20.
47. Morel P, Lepage E, Brice P, Dupriez B, D’Agay MF,
Fenaux P, et al. Prognosis and treatment of lymphoblastic
lymphoma in adults: a report on 80 patients. J Clin
Oncol. 1992; 10: 1078-85.
48. Sweetenham JW, Liberti G, Pearce R, Taghipour G,
Santini G, Goldstone AH. High-dose therapy and autologous
bone marrow transplantation for adult patients
with lymphoblastic lymphoma: results of the European
Group for Bone Marrow Transplantation. J Clin Oncol.
1994; 12: 1358-65.
49. Milpied N, Ifrah N, Kuentz M, Maraninchi D, Colombat
P, Blaise D, et al. Bone marrow transplantation for adult
poor prognosis lymphoblastic lymphoma in first complete
remission. Br J Haemat. 1989; 73: 82-7.
50. Santini G, Coser P, Chisesi T, Porcellini A, Sertoli R,
Contu A, et al. Autologous bone marrow transplantation
for advanced stage adult lymphoblastic lymphoma
in first complete remission. Report of the Non-
Hodgkin’s Lymphoma Cooperative Study Group
(NHLCSG). Ann Oncol. 1991; (Suppl 2) 9: 181-5.
51. Baro J, Richard C, Sierra J, Garcia-Conde J, Garcia
Larana J, Rocha E, et al. Autologous bone marrow